You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 100 No. 4, April 1982 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Disposition of Topical Flurbiprofen in Normal and Aphakic Rabbit Eyes

Janet A. Anderson, PhD; Chi Chu Chen, PhD; Joao Brasil Vita, MD; Martha Shackleton

Arch Ophthalmol. 1982;100(4):642-645.


Abstract

• In a study of the ocular absorption and elimination of a topically applied nonsteroidal anti-inflammatory drug (NSAID), flurbiprofen, the compound was well absorbed into rabbit ocular tissues and was highly concentrated in the rabbit cornea. In aphakic eyes, more drug penetrated to the vitreous and choroid-retina area than in normal rabbit eyes, although corneal concentrations were still high. No ocular metabolism of flurbiprofen could be detected, and the ocular route of application did not lead to any changes in blood elimination rates or metabolism when compared with intravenously injected drug. Currently, no NSAID is available for topical ocular use, and the development of such a drug is desirable for treatment of ocular inflammations, especially when long-term treatment is indicated.



Author Affiliations

From the Department of Ophthalmology, University of California, Irvine (Drs Anderson and Vita); and the Biochemistry Section, Pharmaceutical Sciences, Allergan Pharmaceuticals, Inc, Irvine, Calif (Drs Anderson and Chen and Ms Shackleton).


Footnotes

Accepted for publication July 7, 1981.

Read in part before the Association for Research in Vision and Ophthalmology, Orlando, Fla, May 4, 1980.

Reprint requests to Department of Ophthalmology, University of California, Irvine, CA 92717 (Dr Anderson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multiple Dosing Increases the Ocular Bioavailability of Topically Administered Flurbiprofen
Anderson and Chen
Arch Ophthalmol 1988;106:1107-1109.
ABSTRACT  

Comparative In Vivo Inhibitory Effects of Nonsteroidal Anti-inflammatory Agents on Prostaglandin Synthesis in Rabbit Ocular Tissues
Kulkarni and Srinivasan
Arch Ophthalmol 1985;103:103-106.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.